Brolizum (Pembrolizumab) 100mg/4ml

Brolizum 100mg/4ml delivers Pembrolizumab, a checkpoint inhibitor that helps the immune system fight many advanced and metastatic cancers. PakMeds only arranges Brolizum for patients who have approval from an attending oncologist in a verified cancer hospital in accordance with DRAP NOC.

Brolizum Ingredients and Usage

Brolizum contains Pembrolizumab, a humanized monoclonal antibody that targets the PD-1 immune checkpoint. A checkpoint inhibitor is a drug that releases the natural brakes on cancer fighting immune cells. Oncologists use Brolizum for stage III melanoma, non small cell lung cancer, renal cell carcinoma, and cutaneous squamous cell carcinoma.

Brolizum also treats advanced cervical cancer, gastric or gastroesophageal junction cancer, breast cancer, and locally advanced or metastatic urothelial cancer. A specialist gives Brolizum as an intravenous infusion, commonly 200mg every three weeks or 400mg every six weeks. Doctors confirm the tumor type and may test PD-L1 levels before starting Brolizum.

How Does Brolizum Work?

Brolizum works by binding PD-1, a receptor that cancer cells exploit to switch off attacking T cells. By blocking the link between PD-1 and its partner proteins PD-L1 and PD-L2, Pembrolizumab reactivates the immune response. The awakened T cells then identify and kill cancer cells across many tumor types.

Brolizum acts on the immune system instead of directly destroying cells the way chemotherapy or radiation does. In clinical trials, Pembrolizumab extended survival for patients with metastatic melanoma, lung cancer, and head and neck squamous cell carcinoma. Because each tumor responds differently, oncologists track scans and bloodwork throughout treatment.

Brolizum Side Effects

Brolizum can overstimulate the immune system, causing inflammation in healthy organs that needs early attention. Tell your cancer team about any new or worsening symptom during and after treatment.

• Tiredness and low energy

• Skin rash or itching

• Diarrhea or bowel inflammation

• Reduced appetite and nausea

• Breathing problems or cough

• Underactive or overactive thyroid

• Muscle and joint pain

• Headache

• Infusion related fever and chills

• Abnormal liver test results

Warnings

• Brolizum can cause immune mediated pneumonitis, colitis, hepatitis, nephritis, and hormone gland disorders that may be life threatening.

• Severe skin reactions, including rare blistering conditions, have occurred with pembrolizumab and need urgent care.

• Brolizum can harm a developing baby. Use reliable contraception during therapy and for four months after the final dose.

• Patients who had or plan an allogeneic stem cell transplant face added risks, so tell your doctor before starting Brolizum.

• Avoid live vaccines while receiving Brolizum, since the immune response may be unpredictable.

• Counterfeit Keytruda is flooding the market. Always confirm authenticity and buy pembrolizumab only from traceable sources, as our counterfeit Keytruda blog explains.

Brolizum Storage Conditions

Store Brolizum 100mg/4ml refrigerated at 2°C to 8°C in its original carton, shielded from direct light. Do not freeze the vial and do not shake it, since rough handling breaks down the Pembrolizumab protein. Keep Brolizum away from children, and let trained staff dilute and infuse the medicine.